PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Haofei Wang

Nanfang Hospital

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · JOURNAL ARTICLE

Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC

Frontiers in Immunology

Retrospective analysis across multiple cohorts showing associations between intratumoral heterogeneity and immunotherapy response and recurrence, but limited by observational design, lack of prospective validation, and surrogate endpoints rather than hard clinical outcomes.

PromisingRadiomics and Machine Learning in Medical Imaging Haofei Wang Yuhang Wang

Reported

Sample size (advanced NSCLC immun…504

Sample size (early-stage surgical…121

NGS testing panel scope (surgical…733-panel

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support